InvestorsHub Logo
Followers 14
Posts 806
Boards Moderated 0
Alias Born 06/26/2014

Re: Gator328 post# 371650

Thursday, 08/25/2022 12:30:29 PM

Thursday, August 25, 2022 12:30:29 PM

Post# of 469036
What would be awesome if that CTAD has sessions led by scientists who peer reviewed the last two articles highlighting the MOA of the SIGMAR1 receptor, then Missling speaks about the great AD trial results.

It would ultimately set up the paradigm shift in the CNS world, and catapult Anavex to becoming the most exciting drug in the world!
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News